Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Regional and cellular gene expression changes in human Huntington's disease brain.

Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, Hollingsworth ZR, Collin F, Synek B, Holmans PA, Young AB, Wexler NS, Delorenzi M, Kooperberg C, Augood SJ, Faull RL, Olson JM, Jones L, Luthi-Carter R.

Hum Mol Genet. 2006 Mar 15;15(6):965-77. Epub 2006 Feb 8.

PMID:
16467349
2.

Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.

Augood SJ, Faull RL, Emson PC.

Ann Neurol. 1997 Aug;42(2):215-21.

PMID:
9266732
3.

Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients.

Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voorn P.

Ann Neurol. 1995 Dec;38(6):852-61.

PMID:
8526457
4.
5.

Metabolic changes in the basal ganglia of patients with Huntington's disease: an in situ hybridization study of cytochrome oxidase subunit I mRNA.

Gourfinkel-An I, Vila M, Faucheux B, Duyckaerts C, Viallet F, Hauw JJ, Brice A, Agid Y, Hirsch EC.

J Neurochem. 2002 Feb;80(3):466-76.

6.

Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases.

Jauch D, Urbańska EM, Guidetti P, Bird ED, Vonsattel JP, Whetsell WO Jr, Schwarcz R.

J Neurol Sci. 1995 May;130(1):39-47.

PMID:
7650530
7.

Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry.

Runne H, Régulier E, Kuhn A, Zala D, Gokce O, Perrin V, Sick B, Aebischer P, Déglon N, Luthi-Carter R.

J Neurosci. 2008 Sep 24;28(39):9723-31. doi: 10.1523/JNEUROSCI.3044-08.2008.

8.

Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease.

Furtado S, Suchowersky O, Rewcastle B, Graham L, Klimek ML, Garber A.

Ann Neurol. 1996 Jan;39(1):132-6.

PMID:
8572659
9.

The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain.

Curtis MA, Penney EB, Pearson J, Dragunow M, Connor B, Faull RL.

Neuroscience. 2005;132(3):777-88.

PMID:
15837138
10.

Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues.

Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, Swaroop M, Kaatz KW, Collins FS, Albin RL.

Nat Genet. 1993 Nov;5(3):259-65.

PMID:
8275091
12.

Gene expression changes in blood as a putative biomarker for Huntington's disease.

Lovrecic L, Kastrin A, Kobal J, Pirtosek Z, Krainc D, Peterlin B.

Mov Disord. 2009 Nov 15;24(15):2277-81. doi: 10.1002/mds.22477.

PMID:
19844910
13.

Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease.

Singhrao SK, Neal JW, Morgan BP, Gasque P.

Exp Neurol. 1999 Oct;159(2):362-76.

PMID:
10506508
14.

Generalized brain and skin proteasome inhibition in Huntington's disease.

Seo H, Sonntag KC, Isacson O.

Ann Neurol. 2004 Sep;56(3):319-28.

PMID:
15349858
15.

Brain structure in preclinical Huntington's disease.

Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC.

Biol Psychiatry. 2006 Jan 1;59(1):57-63. Epub 2005 Aug 22.

PMID:
16112655
16.

A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain.

Curtis MA, Waldvogel HJ, Synek B, Faull RL.

J Chem Neuroanat. 2005 Jul;30(1):55-66.

PMID:
16108100
17.

Early and progressive accumulation of reactive microglia in the Huntington disease brain.

Sapp E, Kegel KB, Aronin N, Hashikawa T, Uchiyama Y, Tohyama K, Bhide PG, Vonsattel JP, DiFiglia M.

J Neuropathol Exp Neurol. 2001 Feb;60(2):161-72.

PMID:
11273004
18.

Reduced striatal [3H]inositol 1,4,5-trisphosphate binding in Huntington's disease.

Warsh JJ, Politsky JM, Li PP, Kish SJ, Hornykiewicz O.

J Neurochem. 1991 Apr;56(4):1417-22.

PMID:
1825844
19.

Striatal specificity of gene expression dysregulation in Huntington's disease.

Thomas EA.

J Neurosci Res. 2006 Nov 1;84(6):1151-64. Review.

PMID:
16983659
20.

Increase in kynurenic acid in Huntington's disease motor cortex.

Connick JH, Carlà V, Moroni F, Stone TW.

J Neurochem. 1989 Mar;52(3):985-7.

PMID:
2521895

Supplemental Content

Support Center